Agonist binding and activation of the rat β1-adrenergic receptor: Role of Trp134 (3.28), Ser190 (4.57) and Tyr356 (7.43)

Linda A. Rezmann-Vitti, Simon N S Louis, Tracy L. Nero, Graham P. Jackman, Dimitri Iakovidis, Curtis Machida, William J. Louis

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We investigated the role of Trp134 (3.28), Ser 190 (4.57) and Tyr356 (7.43) in agonist binding to, and activation of, the rat β1-adrenergic receptor by comparing pKis and functional responses of W134A, S190A and Y356F mutant receptors to wild type, all stably expressed in CHO cells. All three mutations significantly (P <0.05) reduced adenylyl cyclase intrinsic activity (IA) compared to wild type in response to stimulation with both (-)-isoprenaline (53-88%) and (-)-RO363 (46-61%), and there was no significant correlation either between IA or pD2 and pKi (P > 0.4), suggesting that changes in pKi were not sufficient to explain the fall in adenylyl cyclase activity. The most pronounced reduction in affinity (126-fold, P <0.01) was displayed by xamoterol for the Y356F mutation, suggesting that xamoterol is able to directly interact with Tyr356 (7.43). For the other agonists, the change in pKi values for the mutant receptors ranged from a 20-fold decrease to a 2-fold increase compared to the wild type. In a three-dimensional model of the rat β1-adrenergic receptor, Trp134 (3.28) and Tyr356 (7.43) form part of a hydrophobic binding pocket involving residues in transmembrane helices 1, 2, 3 and 7. Our results suggest that Trp134 (3.28) and Tyr356 (7.43), together with Trp353 (7.40), are able to interact via π-π interactions to stabilize the extracellular ends of transmembrane helices 3 and 7. Ser190 (4.57) appears to be involved in a hydrogen bonding network, which maintains the spatial relationship between transmembrane helices 3 and 4. These interhelical interactions suggest that the three mutated residues stabilize the active receptor state by maintaining the proper packing of their respective transmembrane helix within the helix bundle, facilitating the appropriate movement and rotation of the transmembrane regions during the activation process.

Original languageEnglish (US)
Pages (from-to)675-688
Number of pages14
JournalBiochemical Pharmacology
Volume68
Issue number4
DOIs
StatePublished - Aug 15 2004

Fingerprint

Xamoterol
Adrenergic Receptors
Rats
Chemical activation
Mutation
CHO Cells
Hydrogen Bonding
Adenylyl Cyclases
Hydrogen bonds

Keywords

  • β-adrenergic receptor
  • β-AR
  • adenosine 3′:5′-cyclic monophosphate
  • cAMP
  • Chinese hamster ovary
  • CHO
  • G-protein-coupled receptor
  • GPCR
  • M
  • M muscarinic acetylcholine receptor
  • tm
  • transmembrane
  • wild type
  • WT

ASJC Scopus subject areas

  • Pharmacology

Cite this

Agonist binding and activation of the rat β1-adrenergic receptor : Role of Trp134 (3.28), Ser190 (4.57) and Tyr356 (7.43). / Rezmann-Vitti, Linda A.; Louis, Simon N S; Nero, Tracy L.; Jackman, Graham P.; Iakovidis, Dimitri; Machida, Curtis; Louis, William J.

In: Biochemical Pharmacology, Vol. 68, No. 4, 15.08.2004, p. 675-688.

Research output: Contribution to journalArticle

Rezmann-Vitti, Linda A. ; Louis, Simon N S ; Nero, Tracy L. ; Jackman, Graham P. ; Iakovidis, Dimitri ; Machida, Curtis ; Louis, William J. / Agonist binding and activation of the rat β1-adrenergic receptor : Role of Trp134 (3.28), Ser190 (4.57) and Tyr356 (7.43). In: Biochemical Pharmacology. 2004 ; Vol. 68, No. 4. pp. 675-688.
@article{13c0fcaf467b40e5a3ff17cb632a81ad,
title = "Agonist binding and activation of the rat β1-adrenergic receptor: Role of Trp134 (3.28), Ser190 (4.57) and Tyr356 (7.43)",
abstract = "We investigated the role of Trp134 (3.28), Ser 190 (4.57) and Tyr356 (7.43) in agonist binding to, and activation of, the rat β1-adrenergic receptor by comparing pKis and functional responses of W134A, S190A and Y356F mutant receptors to wild type, all stably expressed in CHO cells. All three mutations significantly (P <0.05) reduced adenylyl cyclase intrinsic activity (IA) compared to wild type in response to stimulation with both (-)-isoprenaline (53-88{\%}) and (-)-RO363 (46-61{\%}), and there was no significant correlation either between IA or pD2 and pKi (P > 0.4), suggesting that changes in pKi were not sufficient to explain the fall in adenylyl cyclase activity. The most pronounced reduction in affinity (126-fold, P <0.01) was displayed by xamoterol for the Y356F mutation, suggesting that xamoterol is able to directly interact with Tyr356 (7.43). For the other agonists, the change in pKi values for the mutant receptors ranged from a 20-fold decrease to a 2-fold increase compared to the wild type. In a three-dimensional model of the rat β1-adrenergic receptor, Trp134 (3.28) and Tyr356 (7.43) form part of a hydrophobic binding pocket involving residues in transmembrane helices 1, 2, 3 and 7. Our results suggest that Trp134 (3.28) and Tyr356 (7.43), together with Trp353 (7.40), are able to interact via π-π interactions to stabilize the extracellular ends of transmembrane helices 3 and 7. Ser190 (4.57) appears to be involved in a hydrogen bonding network, which maintains the spatial relationship between transmembrane helices 3 and 4. These interhelical interactions suggest that the three mutated residues stabilize the active receptor state by maintaining the proper packing of their respective transmembrane helix within the helix bundle, facilitating the appropriate movement and rotation of the transmembrane regions during the activation process.",
keywords = "β-adrenergic receptor, β-AR, adenosine 3′:5′-cyclic monophosphate, cAMP, Chinese hamster ovary, CHO, G-protein-coupled receptor, GPCR, M, M muscarinic acetylcholine receptor, tm, transmembrane, wild type, WT",
author = "Rezmann-Vitti, {Linda A.} and Louis, {Simon N S} and Nero, {Tracy L.} and Jackman, {Graham P.} and Dimitri Iakovidis and Curtis Machida and Louis, {William J.}",
year = "2004",
month = "8",
day = "15",
doi = "10.1016/j.bcp.2004.04.021",
language = "English (US)",
volume = "68",
pages = "675--688",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Agonist binding and activation of the rat β1-adrenergic receptor

T2 - Role of Trp134 (3.28), Ser190 (4.57) and Tyr356 (7.43)

AU - Rezmann-Vitti, Linda A.

AU - Louis, Simon N S

AU - Nero, Tracy L.

AU - Jackman, Graham P.

AU - Iakovidis, Dimitri

AU - Machida, Curtis

AU - Louis, William J.

PY - 2004/8/15

Y1 - 2004/8/15

N2 - We investigated the role of Trp134 (3.28), Ser 190 (4.57) and Tyr356 (7.43) in agonist binding to, and activation of, the rat β1-adrenergic receptor by comparing pKis and functional responses of W134A, S190A and Y356F mutant receptors to wild type, all stably expressed in CHO cells. All three mutations significantly (P <0.05) reduced adenylyl cyclase intrinsic activity (IA) compared to wild type in response to stimulation with both (-)-isoprenaline (53-88%) and (-)-RO363 (46-61%), and there was no significant correlation either between IA or pD2 and pKi (P > 0.4), suggesting that changes in pKi were not sufficient to explain the fall in adenylyl cyclase activity. The most pronounced reduction in affinity (126-fold, P <0.01) was displayed by xamoterol for the Y356F mutation, suggesting that xamoterol is able to directly interact with Tyr356 (7.43). For the other agonists, the change in pKi values for the mutant receptors ranged from a 20-fold decrease to a 2-fold increase compared to the wild type. In a three-dimensional model of the rat β1-adrenergic receptor, Trp134 (3.28) and Tyr356 (7.43) form part of a hydrophobic binding pocket involving residues in transmembrane helices 1, 2, 3 and 7. Our results suggest that Trp134 (3.28) and Tyr356 (7.43), together with Trp353 (7.40), are able to interact via π-π interactions to stabilize the extracellular ends of transmembrane helices 3 and 7. Ser190 (4.57) appears to be involved in a hydrogen bonding network, which maintains the spatial relationship between transmembrane helices 3 and 4. These interhelical interactions suggest that the three mutated residues stabilize the active receptor state by maintaining the proper packing of their respective transmembrane helix within the helix bundle, facilitating the appropriate movement and rotation of the transmembrane regions during the activation process.

AB - We investigated the role of Trp134 (3.28), Ser 190 (4.57) and Tyr356 (7.43) in agonist binding to, and activation of, the rat β1-adrenergic receptor by comparing pKis and functional responses of W134A, S190A and Y356F mutant receptors to wild type, all stably expressed in CHO cells. All three mutations significantly (P <0.05) reduced adenylyl cyclase intrinsic activity (IA) compared to wild type in response to stimulation with both (-)-isoprenaline (53-88%) and (-)-RO363 (46-61%), and there was no significant correlation either between IA or pD2 and pKi (P > 0.4), suggesting that changes in pKi were not sufficient to explain the fall in adenylyl cyclase activity. The most pronounced reduction in affinity (126-fold, P <0.01) was displayed by xamoterol for the Y356F mutation, suggesting that xamoterol is able to directly interact with Tyr356 (7.43). For the other agonists, the change in pKi values for the mutant receptors ranged from a 20-fold decrease to a 2-fold increase compared to the wild type. In a three-dimensional model of the rat β1-adrenergic receptor, Trp134 (3.28) and Tyr356 (7.43) form part of a hydrophobic binding pocket involving residues in transmembrane helices 1, 2, 3 and 7. Our results suggest that Trp134 (3.28) and Tyr356 (7.43), together with Trp353 (7.40), are able to interact via π-π interactions to stabilize the extracellular ends of transmembrane helices 3 and 7. Ser190 (4.57) appears to be involved in a hydrogen bonding network, which maintains the spatial relationship between transmembrane helices 3 and 4. These interhelical interactions suggest that the three mutated residues stabilize the active receptor state by maintaining the proper packing of their respective transmembrane helix within the helix bundle, facilitating the appropriate movement and rotation of the transmembrane regions during the activation process.

KW - β-adrenergic receptor

KW - β-AR

KW - adenosine 3′:5′-cyclic monophosphate

KW - cAMP

KW - Chinese hamster ovary

KW - CHO

KW - G-protein-coupled receptor

KW - GPCR

KW - M

KW - M muscarinic acetylcholine receptor

KW - tm

KW - transmembrane

KW - wild type

KW - WT

UR - http://www.scopus.com/inward/record.url?scp=3242681532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242681532&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2004.04.021

DO - 10.1016/j.bcp.2004.04.021

M3 - Article

C2 - 15276075

AN - SCOPUS:3242681532

VL - 68

SP - 675

EP - 688

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 4

ER -